Surgery Partners

SGRY

Market cap $2.21B

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

It missed on the top line and whiffed significantly on analyst estimates in its third quarter. The company did manage to grow its revenue by almost 7% year over year.

Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Ryan Langston - TD Cowen, Research Division Presentation Operator Greetings, and welcome to the Surgery Partners' Third Quarter 2025 Earnings Call.

Surgery Partners (SGRY) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, Ltd., has announced the acquisition of a minority ownership interest in Valley Ambulatory Surgery Center (Valley ASC) in partnership with Surgery Partners. This collaboration strengthens Duly's commitment to expanding access to high-quality, affordable outpatient surgical care across the Chicagoland area. Valley ASC, located in St. Charles, Illinois, is a respected, multispec.

Surgery Partners (SGRY -0.34%), a leading operator of ambulatory surgical facilities, announced its results for the second quarter on August 5, 2025. The company reported GAAP revenue of $826.2 million, surpassing analyst GAAP estimates of $818.4 million, while Non-GAAP earnings per share (EPS) came in at $0.17, slightly missing the $0.18 consensus (non-GAAP).

Surgery Partners, Inc. (NASDAQ:SGRY ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants David T. Doherty - Executive VP & CFO J.

Surgery Partners (SGRY) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.21 per share a year ago.

BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025.

BRENTWOOD, Tenn., July 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2025 results before the market opens on Tuesday, August 5, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time).